retatrutide ly3437943 glp-1 gip glucagon receptor agonist triple mechanism Beyond GLP -1: Retatrutide's triple-agonist (GLP-1, GIP, glucagon) is redefining metabolic health. Phase 2 data shows ~24% weight loss—surpassing semaglutide & tirzepatide. Evidence-based Retatrutide: How Triple GLP-1/GIP/Glucagon Receptor

Orforglipron, an investigational once-daily oral GLP-1 receptor agonist developed by Eli Lilly, has just completed a series of landmark Phase 3 trials

A., Susova, O

There's no well-established list of major drug interactions for healthy adults at standard doses, but anyone on regular medication, especially chemotherapy, should still confirm with their doctor first, since antioxidant supplements can theoretically interact with certain treatments

Melanotan 2 and Cognition Melanotan 2 also appears to have potential benefit on cognition by binding to melanocortin receptors in the brain that are lost over time with age [15]

[DOI] [PubMed] [Google Scholar] 11.Matsui R., Xu S., Maitland K